Sub specialities: Haemostasis and thrombosis
Dr Ahmed worked as a locum consultant haematologist at St Vincent's University Hospital before his appointment as a consultant haematologist at the National Coagulation Centre at St James’s Hospital in September 2019.
Dr Ahmed received his medical degree and internship training in Khartoum, Sudan before moving to Ireland in 2007.
He completed his basic medical training in St James’s Hospital and Tallaght University Hospital. He completed his Higher Specialist Training in clinical and laboratory haematology in Ireland in 2019.
Dr Ahmed is the hospital’s lead investigator in a multicentre clinical study (TILLIRI Study), investigating incidence and risk factors for deep vein thrombosis (DVT) in patients who require lower limb immobilisation. He is also a sub-investigator in the first gene therapy trial in haemophilia in Ireland “UniQure study” and in Haven trial (phase III trial of emicizumab prophylaxis in haemophilia A patients).
His research on the mechanisms of the increase in factor IX (FIX) levels in children with haemophilia B Leyden, was published at the British Journal of Haematology and presented at the European Haematology Association Congress.
Dr Ahmed conducted basic laboratory research in chronic lymphocytic leukaemia at the Royal College of Surgeons in Ireland (RCSI), The Laboratory for Molecular Medicine and Beaumont Hospital for two years and presented his research at national and international meetings.